Blockchain tech would make cannabis clinical trials more secure and efficient
In jurisdictions where cannabis is legal or soon-to-be legal, the general public is beginning to understand the benefits and medicinal potential of cannabinoids. Key to this process is the increased legitimacy of a growing global cannabis industry.
Today’s cannabis products are subject to a higher degree of scrutiny than ever before with each participating jurisdiction enforcing strict regulations for quality, safety and accuracy of dosing. The standards to which medical cannabis products must follow mirror those followed by traditional pharmaceuticals for decades, and so the role of a rigorous clinical trials process has become critical to the medical cannabis industry.
The global market for clinical trials is expected to reach 65.2 billion by 2025.